Combination Improves Survival , Mesothelioma Research:

The following are the results of research mesothelioma which is reported in the last topic of the Journal of Clinical Oncology. Mesothelioma researchers to combine Tomudex (raltitrexed) and Platinol (cisplatin) has shown impressive results in improving the survival of patients suffering from mesothelioma Pleural rare malignant usually caused by exposure to asbestos. According to mesothelioma According to the research findings in the journal, a combination of both treatments significantly improved survival of patients compared with the use of Platinol alone. These mesothelioma research findings random out of the third phase of the trial. Patients who suffer from these rare experience of mesothelioma usually shortness of breath, cough, pain, fatigue, loss of appetite. These new research findings mesothelioma is the most encouraging, because this type of cancer has proved to be resistant to most treatments such as surgery, chemotherapy and even the same when combined with radiation. Usually is more complicated by the fact that patients are usually not aware of the fact that they suffer from mesothelioma Pleural malignant disease has made so already very advanced stage where treatment with surgery or radiation is no longer a viable option. This is the reason for the indication of treatment can improve survival and quality of life of patients, as this research mesothelioma promises, is important. Visit the author's mesothelioma research mesothelioma blog for the latest research findings.